The oxidized nitric oxide (NO) metabolites nitrite (NO2−) and nitrate (NO3−) have been used as markers of NO synthase activity in several clinical and experimental studies including those investigating sepsis (1)(2)(3)(4), septic shock (5), endotoxemia (6)(7), cardiac transplant (8), hypertension (9), and cancer (10). Although the NO chemiluminescence methodology has been used to measure NO2− and NO3− (11)(12)(13), there are few reports evaluating the operating conditions of the assay. The operating efficiency of the NO chemiluminescent system is governed by several variables: driving pressure and flow rate of the carrier gas (14)(15), which determine the degree of mixing in reducing solution and dispersion of NO in the carrier gas stream; chemiluminescent reaction chamber pressure (PRC); and the selectivity (16), pH (11), temperature (13), and concentration of the reducing agents used to convert NO2− and NO3− to NO. Yang et al. (13) studied the efficiency of conversion of both NO2− and NO3− to NO using various reducing agents over a range of operating temperatures; however, no studies on the relationship between carrier gas flow rate and PRC have been reported.
No takes yet. Share an insight, caveat, or question.
Bateman et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: